Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL prolonged-release tablets, due to the occurrence of incorrect tablet counts in the bottles. The majority of reports are for missing tablets but extra tablets have also been reported. 

View the affected batches.

The defect will impact reconciliation of the Schedule 2 Controlled Drugs. Product is not being recalled.

Healthcare teams are asked to manually check affected batches, which may include breaking the tamper evident seal. Please report any affected packs to licensed@ethypharm.com using the reference Ethypharm supply for any reconciliation excursions.

Patients should be made aware of the count issue, and be advised to return for their next prescription as needed. 

For all medical information enquiries and information on this product, please email medinfo@ethypharm.com or telephone 01277 266 600 Selecting Option 2.

For stock control enquiries please email licensed@ethypharm.com, or telephone 01628 551900.